Jenscare Scientific: Clinical Trials

5 trials sponsored by Jenscare Scientific, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown, 1 active not recruiting, 1 completed, 1 recruiting. 5 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable5Unknown 2, Active not recruiting 1, Completed 1, Recruiting 1

Follow Jenscare Scientific: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Robotic Transjugular Transcatheter Tricuspid Valve Replacement
Transcatheter tricuspid valve replacement - Tricuspid Regurgitation (TR), Valvular Heart Diseases
Not applicableRecruitingPrince of Wales Hospital, Shatin, Hong Kong102026-03-122026-09-18
LuX-Valve Plus System for Severe or Greater Tricuspid Regurgitation
Transvenous Tricuspid Valve System implantation + OMT, OMT - Tricuspid Regurgitation (TR)
Not applicableActive not recruitingJenscare Scientific1262024-10-092026-07-15
The JensClip Transcatheter Valve Repair System for Treating Functional Mitral Regurgitation
moderate-severe or greater (MR ≥ 3+) functional mitral regurgitation (FMR) patients - Functional Mitral Regurgitation
Not applicableUnknownJenscare Scientific1292023-08-012023-07-05
A Study to Evaluate the Safety and Performance of LuX-Valve Plus System for Tricuspid Replacement
Transcatheter Tricuspid Valve Intervention - Tricuspid Regurgitation
Not applicableCompletedJenscare Scientific1612023-05-232025-05-21
A Prospective, Multicenter Study to Evaluate the JensClip Transcatheter Valve Repair System
JensClip transcatheter valve repair system - Degenerative Mitral Valve Disease, Mitral Valve Regurgitation
Not applicableUnknownJenscare Scientific1242022-06-012022-06-14

Conditions studied

Tricuspid Valve Insufficiency (3)  ·  Heart Valve Diseases (1)  ·  Mitral Valve Insufficiency (1)

Countries

China (2)  ·  France (1)  ·  Hong Kong (1)

Top investigators

Shengshou Hu (1)